Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fallopian Tubes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00536523
What this trial is testing

Effect of Serotonin Level on Constipation Caused by Chemotherapy in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
ConstipationBowel ObstructionFallopian Tube Cancer+2 more
University of Minnesota 13
Early research (Phase 1)Ended earlyNCT05769959
What this trial is testing

Study of RO7515629 in Participants With HLA-G Positive Solid Tumors

Who this might be right for
Renal Cell CarcinomaNon-small Cell Lung CancerPancreatic Adenocarcinoma+2 more
Hoffmann-La Roche 3
Not applicableStudy completedNCT02668913
What this trial is testing

LCC-CARIS-01: Molecular Profiling in Gynaecological Cancer

Who this might be right for
Epithelial Ovarian CancerPeritoneal CancerFallopian Tube Cancer+1 more
Geoff Hall 72
Not applicableLooking for participantsNCT06988774
What this trial is testing

Assessment of Tubal Occlusion During Minimally Invasive Myomectomy

Who this might be right for
Fallopian Tube Patency TestsFibroid/Myoma (Uterus/Cervix)Myomectomy+1 more
Medstar Health Research Institute 50
Large-scale testing (Phase 3)Active Not RecruitingNCT04498117
What this trial is testing

Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

Who this might be right for
Carcinoma, Ovarian EpithelialOvarian NeoplasmsOvarian Cancer+7 more
CanariaBio Inc. 615
Not applicableEnded earlyNCT01096381
What this trial is testing

Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor

Who this might be right for
Breast CancerCardiovascular ComplicationsColorectal Cancer+6 more
Vanderbilt-Ingram Cancer Center 8
Testing effectiveness (Phase 2)Study completedNCT02889900
What this trial is testing

Efficacy and Safety Study of Cediranib in Combination With Olaparib in Patients With Recurrent Platinum-Resistant Ovarian Cancer

Who this might be right for
Recurrent Platinum Resistant Ovarian Cancer
AstraZeneca 62
Early research (Phase 1)Study completedNCT02275039
What this trial is testing

P53MVA Vaccine and Gemcitabine Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer

Who this might be right for
Recurrent Ovarian Epithelial CancerRecurrent Fallopian Tube CarcinomaRecurrent Primary Peritoneal Carcinoma
City of Hope Medical Center 12
Testing effectiveness (Phase 2)Study completedNCT01767675
What this trial is testing

Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tubes CancerPeritoneal Cancer
Memorial Sloan Kettering Cancer Center 99
Large-scale testing (Phase 3)UnknownNCT03180177
What this trial is testing

Efficacy of HIPEC as NACT and Postoperative Chemotherapy in the Treatment of Advanced-Stage Epithelial Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Shu-Zhong Cui 263
Testing effectiveness (Phase 2)UnknownNCT03462212
What this trial is testing

Carboplatin-Paclitaxel-Bevacizumab vs Carbo-Pacli-Beva-Rucaparib vs Carbo-Pacli-Ruca, Selected According to HRD Status, in Patients With Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer, Preceded by a Phase I Dose Escalation Study on Ruca-Beva Combination

Who this might be right for
Advanced (Stage IIIB-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 290
Testing effectiveness (Phase 2)Study completedNCT00157560
What this trial is testing

Phase II Study of Modified Triple Doublet Therapy in Women With Newly Diagnosed Mullerian Carcinoma

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Massachusetts General Hospital 83
Not applicableStudy completedNCT06184867
What this trial is testing

Choices About Genetic Testing And Learning Your Risk With Smart Technology

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer+5 more
Rutgers, The State University of New Jersey 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06602063
What this trial is testing

Surgery for Relapsed Ovarian Cancer in Precision

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Shanghai Gynecologic Oncology Group 33
Early research (Phase 1)Study completedNCT02996825
What this trial is testing

Mirvetuximab Soravtansine and Gemcitabine Hydrochloride in Treating Patients With FRalpha-Positive Recurrent Ovarian, Primary Peritoneal, Fallopian Tube, Endometrial, or Triple Negative Breast Cancer

Who this might be right for
Recurrent Breast CarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Ovarian Carcinoma+3 more
City of Hope Medical Center 44
Testing effectiveness (Phase 2)Study completedNCT02657889
What this trial is testing

Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer

Who this might be right for
NeoplasmsTriple Negative Breast CancerOvarian Cancer+6 more
Tesaro, Inc. 122
Early research (Phase 1)Ended earlyNCT04025216
What this trial is testing

CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers

Who this might be right for
Non-Small Cell Lung CancerOvarian CancerFallopian Tube Cancer+3 more
Kite, A Gilead Company 16
Early research (Phase 1)Study completedNCT05483933
What this trial is testing

Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers

Who this might be right for
Platinum-resistant Ovarian CancerFallopian Tube CancerEpithelial Ovarian Cancer+4 more
Shattuck Labs, Inc. 86
Early research (Phase 1)UnknownNCT02433626
What this trial is testing

Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies

Who this might be right for
Ovarian CancerFallopian Tube CancerEndometrial Cancer+7 more
Critical Outcome Technologies Inc. 51
Testing effectiveness (Phase 2)Looking for participantsNCT03983226
What this trial is testing

Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial)

Who this might be right for
Ovarian Cancer RecurrentFallopian Tube CancerPrimary Peritoneal Carcinoma
Shanghai Gynecologic Oncology Group 167
Next Page